John F. Paolini
2022
In 2022, John F. Paolini earned a total compensation of $1.9M as Senior Vice President and Chief Medical Officer at Kiniksa Pharmaceuticals, Ltd., a 5% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $226,919 |
|---|---|
| Option Awards | $936,346 |
| Salary | $514,583 |
| Stock Awards | $230,469 |
| Other | $12,200 |
| Total | $1,920,518 |
Paolini received $936.3K in option awards, accounting for 49% of the total pay in 2022.
Paolini also received $226.9K in non-equity incentive plan, $514.6K in salary, $230.5K in stock awards and $12.2K in other compensation.
Rankings
In 2022, John F. Paolini's compensation ranked 1,820th out of 5,753 executives tracked by ExecPay. In other words, Paolini earned more than 68.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,820 out of 5,753 | 68th |
Division Manufacturing | 956 out of 3,133 | 70th |
Major group Chemicals And Allied Products | 390 out of 1,419 | 73rd |
Industry group Drugs | 356 out of 1,320 | 73rd |
Industry Pharmaceutical Preparations | 255 out of 966 | 74th |
Source: SEC filing on April 27, 2023.
Paolini's colleagues
We found two more compensation records of executives who worked with John F. Paolini at Kiniksa Pharmaceuticals, Ltd. in 2022.